A 24 week pilot, double-blind, randomized, parallel, placebo controlled study of memantine and constraint-induced language therapy in chronic poststroke aphasia: Correlation with cognitive evoked potentials during recovery
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Memantine (Primary)
- Indications Aphasia
- Focus Therapeutic Use
- 25 Apr 2015 Pooled analysis results of this trial and other two 24-Week , placebo-controlled trials presented at the 67th Annual Meeting of the American Academy of Neurology.
- 10 Apr 2008 New trial record.